On this page
At a glance
| Quick fact | Details |
|---|---|
| Group | Lactobacillus (name unchanged after the 2020 reclassification) |
| Natural home | Healthy vaginal microbiome; also detected in urine samples |
| Role in FemiCore | Headline probiotic for female urogenital balance |
| Amount in FemiCore | Not disclosed (part of a 50 mg blend) |
| Evidence level | Early clinical research; strain-specific |
| Main cautions | Seriously ill or immunocompromised people |
What is L. crispatus?
L. crispatus is a lactic acid bacterium. In many healthy women of reproductive age, it is the dominant species in the vaginal microbiome. It produces lactic acid, which keeps the vaginal environment mildly acidic, an environment that tends to discourage the overgrowth of unwanted microbes. Scientists also detect it in urine samples from many women.
Why it is included in FemiCore
Because the vagina, urethra and bladder are close neighbors, researchers have become interested in whether supporting L. crispatus may help protect the urinary tract. FemiCore’s marketing places L. crispatus at the center of its microbiome story. The seller’s references include studies of the urinary microbiome in women with incontinence and reviews of probiotics in vaginal health.
Want to see FemiCore’s current offer?
Packages start at $49 per bottle when you choose six, with free US shipping and a 60-day money-back guarantee from the seller. Check the latest price and stock on the seller’s secure checkout.
Check availability & price →Paid link: we may earn a commission at no extra cost to you. Sold by the seller via BuyGoods, not by this site.
What the research shows
Research on L. crispatus is among the more promising in women’s microbiome science. Observational studies consistently associate L. crispatus-dominant vaginal communities with better vaginal health. Some clinical trials have tested specific L. crispatus strains, usually given vaginally rather than by mouth, for preventing recurrent UTIs or bacterial vaginosis, with encouraging but not definitive results. Results from one strain and route cannot be assumed for another, and we have not seen evidence on the specific L. crispatus used in FemiCore, which is not named.
The dose problem: weight, not CFU
FemiCore lists its five probiotics together as a 50 mg blend. Probiotic potency is normally described in colony-forming units (CFU), the number of live organisms able to multiply, along with a specific strain code. A weight figure includes the bacteria plus the carrier powder they are dried with, so it does not tell you how many live L. crispatus cells are in each capsule, or whether they survive until the expiry date. Because benefits are strain- and dose-specific, NIH cautions that it is often unknown which probiotic products help, at what dose, and for whom.
Can oral probiotics reach the urinary tract?
When you swallow a probiotic, it passes through the stomach and intestines. Some researchers think that lactobacilli can move from the gut to the vaginal and perineal area, which may in turn influence the urinary tract. This route is plausible but not fully established, and results vary widely between people. It is one reason why oral probiotics for urinary health remain an open research question rather than a proven approach. A 2015 Cochrane review found no clear evidence that probiotics, as studied so far, reduce UTIs.
Safety
L. crispatus is a member of a bacterial group with a long history of apparently safe use in healthy people, including in fermented foods. NIH notes that the risks of probiotics are higher for people with severe illness or weakened immune systems, and that some products have contained organisms not listed on the label. Possible mild side effects include gas and bloating during the first days.
Ask a doctor first if you: are undergoing chemotherapy, take immunosuppressants, have had an organ transplant, have a central venous catheter, or are seriously ill.
Interactions
Antibiotics can kill probiotic bacteria. If you are prescribed antibiotics, ask your clinician whether to pause FemiCore or space the doses. People on immunosuppressants should seek advice before taking any live probiotic.
Everyday ways to support your own lactobacilli
Supplements are only one influence on your microbiome. Day-to-day habits matter too, and they cost little:
- Use antibiotics only when prescribed, and finish the course as directed.
- Avoid douching and scented intimate products, which can disturb the vaginal microbiome.
- Wear breathable cotton underwear and change out of damp clothing promptly.
- Include fermented foods such as plain yogurt or kefir, if they suit you.
- Stay well hydrated during the day and urinate after sex, a simple step clinicians often suggest for women prone to UTIs.
These habits support a healthy environment regardless of whether you choose to take FemiCore.
Its role in the FemiCore formula
L. crispatus is the most logical probiotic choice for a women’s urinary product and the main justification for FemiCore’s microbiome positioning. Without a strain code or CFU count, though, there is no way to link FemiCore’s L. crispatus to the studies that make this species interesting.
Bottom line
L. crispatus is a smart, well-reasoned inclusion and the most researched species in FemiCore’s probiotic blend. The evidence is still early and strain-specific, so treat it as promising rather than proven. For the whole picture, see the FemiCore ingredients page and our research summary.
Ready to decide?
Packages start at $49 per bottle when you choose six, with free US shipping and a 60-day money-back guarantee from the seller. Check the latest price and stock on the seller’s secure checkout.
Check availability & price →Paid link: we may earn a commission at no extra cost to you. Sold by the seller via BuyGoods, not by this site.
Frequently asked questions
How much L. crispatus is in FemiCore?
The amount is not disclosed. L. crispatus is one of five species in a 50 mg probiotic blend, and the label does not give a CFU count or strain code.
Is L. crispatus safe?
For most healthy adults, L. crispatus is considered low risk, with mild gas or bloating possible at first. People who are seriously ill or immunocompromised should ask a doctor before taking any probiotic.
Is L. crispatus good for UTIs?
Some trials of specific L. crispatus strains, often given vaginally, have shown promise for preventing recurrent UTIs. Results are strain- and route-specific and cannot be assumed for oral blends like FemiCore.
Sources
Last reviewed and updated: October 20, 2026.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.